Speakers & Program

Program

The 2026 CIMT Annual Meeting will feature the latest breakthroughs in translational cancer immunotherapy research, with a program that will span innovative therapies, advances for precise patient selection, and in-depth insights into immune-cancer interactions. Sessions will include focused discussions on Improving Immunity, Tumor Microenvironment, Novel Targets, Cellular Therapies, etc.  

2026 Confirmed Speakers

No items found.

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development